Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Nov;73(11):964-966.
doi: 10.1016/j.rec.2020.07.001. Epub 2020 Jul 9.

Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia

[Article in English, Spanish]
Giuseppe Di Tano  1 , Renata De Maria  2 , Marco Loffi  1 , Luigi Moschini  1 , Gianluca Galeazzi  1 , Gian Battista Danzi  1
Affiliations
Case Reports

Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia

[Article in English, Spanish]
Giuseppe Di Tano et al. Rev Esp Cardiol (Engl Ed). 2020 Nov.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative risk of death or intensive care unit (ICU) admission in patients on angiotensin-converting enzyme inhibitors (ACEIs) (dotted line), angiotensin receptor blockers (ARBs) (thick line), or neither (thin line). Curves for ACEIs and ARBs overlap, indicating comparably lower risk.
See this image and copyright information in PMC

Comment on

References

    1. McKee D.L., Sternberg A., Stange U., Laufer S., Naujokat C.P. Candidate drugs against SARS-CoV-2 and COVID-19. Pharmacol Res. 2020;157:104859. - PMC - PubMed
    1. Hernandez A.V., Roman Y.M., Pasupuleti V., Barboza J.J., Michael White C. Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review. Ann Intern Med. 2020 doi: 10.7326/M20-2496. 10.7326/M20-2496. - DOI - PubMed
    1. Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586–590. - PMC - PubMed
    1. Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259–260. - PMC - PubMed
    1. Jarcho J.A., Ingelfinger J.R., Hamel M.B., D’Agostino R.B., Sr., Harrington D.P. Inhibitors of the renin-angiotensin-aldosterone system and Covid-19. N Engl J Med. 2020;382:2462–2464. - PMC - PubMed

Substances